Seminal studies showed that ablating macrophages genetically by deleting the colony-stimulating factor 1 gene, Csf1, in a transgenic mouse model of breast adenocarcinoma delays tumor development and the angiogenic switch to prevent metastasis [9, 10]. This evidence concerns the gene CSF1 and neoplasm.